Focused research and treatment guidelines needed to ensure ‘behavioral psychedelics’ help patients make lasting change
Blood test may indicate higher risk pregnancies in patients with COVID-19
16 March 2022New study finds higher rates of newly diagnosed type 2 diabetes after infection with mild COVID-19
16 March 2022Focused research and treatment guidelines needed to ensure ‘behavioral psychedelics’ help patients make lasting change
Despite their reputation as illicit drugs, psychedelics may find new, legitimate roles in treatment for anxiety, depression, stress disorders, addiction, and other mental and behavioral health problems. But ensuring they do requires developing rigorous, standardized methods to study and apply the results, according to a new report.
